Corrigendum to “miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2” [Pathol.-Res. Pract. 215(2019), 660–667]
Corrigendum to “miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2” [Pathol.-Res. Pract. 215(2019), 660–667]. // Pathology - Research and Practice. – URL: https://www.sciencedirect.com/science/article/pii/S0344033826004012?dgcid=rss_sd_all
Corrigendum to “miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2” [Pathol.-Res. Pract. 215(2019), 660–667]. Pathology - Research and Practice. https://www.sciencedirect.com/science/article/pii/S0344033826004012?dgcid=rss_sd_all
“Corrigendum to “miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2” [Pathol.-Res. Pract. 215(2019), 660–667].” Pathology - Research and Practice.
@article{article108428,
title = {Corrigendum to “miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2” [Pathol.-Res. Pract. 215(2019), 660–667]},
journal = {Pathology - Research and Practice},
url = {https://www.sciencedirect.com/science/article/pii/S0344033826004012?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....